By a News Reporter-Staff News Editor at Biotech Week -- From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Daniel, Geoffrey A. (Crystal, MN); El-Hage, Fernando (Brooklyn Park, MN); Poucher, Neal (North Oaks, MN), filed on March 18, 2016, was published online on April 10, 2018 (see also Coloplast A/S).
The patent's assignee for patent number 9937320 is Coloplast A/S (Humlebaek, DK).
News editors obtained the following quote from the background information supplied by the inventors: "Urinary incontinence affects about 200 million people worldwide and about 25 million people in the US. Urinary incontinence in women can be associated with a prolapse of one or more pelvic organs, which can arise from a weakness in the tissues/muscle of the pelvic floor. Urinary incontinence in men can arise after surgical treatment of the prostate glade, which treatment can include removal or weakening of the prostatic sphincter associated with the urinary urethra.
"One treatment for urinary incontinence includes placing an artificial sphincter around a circumference of a portion of the urethra. The artificial sphincter operates to compress the urethra to selectively coapt or stop the flow of urine through the urethra, thus providing the user with a continent state. The artificial sphincter can be activated to an open position by the user, which opens the urethra and allows the user to selectively pass urine.
"Surgeons and patients would welcome advances in the treatment of urinary incontinence."
As a supplement to the background information on this patent, NewsRx correspondents also obtained the inventors' summary information for this patent: "One aspect provides a surgical system adapted for dissection of tissue around an organ or around a lumen. The surgical system includes a tissue dissection tool and a catheter. The tissue dissection tool includes a shaft connected between a handle and a tissue dissection head. At least the tissue dissection head of the tissue dissection tool is magnetized to a first polarity. The catheter is insertable into the organ or the lumen, with a wall of the catheter magnetized to the first polarity. When the catheter is inserted into the organ or the lumen, the first polarity of the catheter is configured to repel the first polarity of the tissue dissection head of the tool away from the catheter and away from in the urethra."
For additional information on this patent, see: Daniel, Geoffrey A.; El-Hage, Fernando; Poucher, Neal. Method of Dissecting Tissue. U.S. Patent Number 9937320, filed March 18, 2016, and published online on April 10, 2018. Patent URL: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=9937320.PN.&OS=PN/9937320RS=PN/9937320
Keywords for this news article include: Biotechnology, Biomedical Engineering, Biomedicine, Europe, Denmark, Business, Coloplast A/S, Bioengineering, Health and Medicine, Urinary Incontinence, Artificial Sphincters, Urologic Diseases and Conditions.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC